Latest News
-

AMT-130 at Four Years: Hopeful Signs, Complex Controls
12 min read
uniQure reports that after 4 years, people given high-dose AMT-130 continue to show signs of slower HD progression, providing hope for their recent regulatory submission. But the new analyses are nuanced. We unpack the hopeful, but complex results.
-

2012 Therapeutics Conference: a retrospective
19 min read
HDBuzz looks back at the 2012 Huntington's Disease Therapeutics Conference
-

Mutant yeast highlights crucial CAG-reading protein
5 min read
A new job for a DNA-reading protein called SPT4 – controlling the balance of mutant and healthy huntingtin protein
-

HD Therapeutics Conference 2012 Updates: Day 3
6 min read
Day 3 of our coverage of the Huntington's Disease Therapeutics Conference
-

HD Therapeutics Conference 2012 Updates: Day 2
4 min read
Day 2 of our coverage of the Huntington's Disease Therapeutics Conference
-

HD Therapeutics Conference 2012 Updates: Day 1
5 min read
Day 1 of our coverage of the Huntington's Disease Therapeutics Conference
-

Coming soon: HD Therapeutics Conference 2012
2 min read
Huntington's Disease Therapeutics Conference starts next week. Twitter follow @HDBuzzfeed for live updates!
-

New analysis suggests 'small' CAG length doesn't matter after all
7 min read
Size isn't everything: new research suggests that only a person's big CAG count, not the small one, affects HD onset
-

Special 'brain fat' injection helps HD mice
5 min read
Directly injecting the brains of HD mice with a good type of fat called ganglioside GM1 provides dramatic benefit
-

HDYO! Huntington's Disease Youth Organization goes live
3 min read
The Huntington's Disease Youth Organization website has just launched and its website is now active at www.hdyo.org
-

Could mesenchymal stem cells deliver gene silencing drugs?
6 min read
Stem cells can deliver HD gene silencing drugs into cells in a dish. Do we need another delivery technology?
